Your browser doesn't support javascript.
loading
Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease.
Kessoku, Takaomi; Kobayashi, Takashi; Ozaki, Anna; Iwaki, Michihiro; Honda, Yasushi; Ogawa, Yuji; Imajo, Kento; Saigusa, Yusuke; Yamamoto, Koji; Yamanaka, Takeharu; Usuda, Haruki; Wada, Koichiro; Yoneda, Masato; Saito, Satoru; Nakajima, Atsushi.
Afiliação
  • Kessoku T; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kobayashi T; Department of Palliative Medicine, Yokohama City University Hospital, Yokohama, Japan.
  • Ozaki A; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Iwaki M; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Honda Y; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Ogawa Y; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Imajo K; Department of Palliative Medicine, Yokohama City University Hospital, Yokohama, Japan.
  • Saigusa Y; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yamamoto K; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yamanaka T; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Usuda H; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Wada K; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yoneda M; Department of Pharmacology, Shimane University Faculty of Medicine Graduate School of Medicine, Izumo, Shimane, Japan.
  • Saito S; Department of Pharmacology, Shimane University Faculty of Medicine Graduate School of Medicine, Izumo, Shimane, Japan.
  • Nakajima A; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
BMJ Open ; 10(9): e037961, 2020 09 09.
Article em En | MEDLINE | ID: mdl-32907904
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tiazepinas / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tiazepinas / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão